NTRA

Natera Inc.

Price

$328.18

return (12m)

95.32%

p/e

-243.55

p/bv

25.72

DIVIDEND YIELD

0.00%

NTRA price

Natera

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NTRA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.80%

3 months

47.28%

1 year

95.32%

2 years

190.68%

5 years

175.85%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NTRA

Valuation

P/E

-243.55

Sector -3.73

Industry -3.73

P/BV

25.72

Sector 2.16

Industry 2.16

P/Revenue (PSR)

17.30

Sector 2.15

Industry 2.15

EV/EBITDA

Sector -221.18

Industry -221.18

EV/EBIT

Sector -47.52

Industry -47.52

P/EBITDA

Sector -21.48

Industry -21.48

P/EBIT

Sector -31.80

Industry -31.80

P/Total Assets

17.63

Sector 1.26

Industry 1.26

P/Net Current Assets

56.92

Sector -11.06

Industry -11.06

P/Working Capital

42.36

Sector -190.98

Industry -190.98

EPS

-1.35

Sector -1.77

Industry -1.77

BVPS

12.74

Sector 2.05

Industry 2.05

Efficiency

Gross Margin

63.21%

Sector 41.11%

Industry 41.11%

EBITDA Margin

0.00%

Sector -17,824.00%

Industry -17,824.00%

EBIT Margin

0.00%

Sector -4,221,656.00%

Industry -4,221,656.00%

Operating Margin

-10.70%

Sector -34.64%

Industry -34.64%

Net Profit Margins

-7.11%

Sector -35.45%

Industry -35.45%

Asset Turnover

0.28

Sector 0.03

Industry 0.03

Profitability

ROE

-10.56%

Sector -56.40%

Industry -56.40%

ROA

-7.24%

Sector -59.80%

Industry -59.80%

ROIC

0.00%

Sector -2,338.86%

Industry -2,338.86%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.00

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -14,697,933.03

Industry -14,697,933.03

Net Debt / EBIT

Sector -8.34

Industry -8.34

Net Debt / Equity

0.00

Sector -34,400.71

Industry -34,400.71

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.69

Sector 0.46

Industry 0.46

Liabilities/Assets

0.31

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

34.05%

Sector -

Industry -

5Y Earnings CAGR

-16.42%

Sector -

Industry -

Fundamentals NTRA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NTRA Natera Inc.	$328.18	95.32%	0.00%	-243.55	25.72	-10.56%	-7.11%
JNJ Johnson & Johnson	$268.55	55.04%	1.90%	31.48	7.79	24.76%	21.48%
PFE Pfizer Inc.	$27.90	20.04%	6.01%	37.36	1.91	5.11%	6.86%
ABBV AbbVie Inc.	$251.28	21.99%	2.66%	72.11	-76.75	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.35	-12.29%	3.97%	11.43	6.07	53.11%	35.32%
MRK Merck & Co. Inc.	$148.39	82.03%	2.24%	116.76	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$159.81	-0.34%	1.98%	19.30	4.97	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$65.15	44.76%	3.75%	14.74	6.13	41.55%	18.85%
ZTS Zoetis Inc.	$74.39	-50.55%	2.76%	11.95	10.04	84.02%	27.77%
AMGN Amgen Inc.	$394.27	43.99%	2.25%	26.93	20.14	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$808.72	45.39%	0.44%	19.82	2.71	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$107.62	43.62%	0.00%	31.19	89.88	288.13%	24.86%
MCK McKesson Corporation	$897.85	31.28%	0.36%	20.52	-28.15	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$546.12	37.87%	0.00%	31.75	6.91	21.76%	35.00%
CAH Cardinal Health Inc.	$241.34	63.43%	0.83%	37.62	-21.79	-57.93%	0.62%
ARGX argenx SE	$1,005.55	33.93%	0.00%	3.11	3.48	112.18%	44.41%
HRMY Harmony Biosciences Holdings Inc.	$42.25	17.39%	0.00%	13.47	2.44	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NTRA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Natera

Natera Inc.

Average Investor10 user rating

4.0 (10 people)

United States

19 years

Founded: 2007

2015

Time since IPO - 11 years

1.815

Employees

Natera Inc. (United States) is listed on the Nasdaq and has a market capitalization of $46.84 billion, with shareholders equity totaling $1.82 billion.

The company employs approximately 1.815 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Natera Inc. reported $2.71 billion in revenue, generating net income of $-192.34 million.

Key financial metrics include a P/E ratio of -243.55, a price-to-book (P/B) ratio of 25.72, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NTRA.

Market cap

$46.84 billion

Net worth

$1.82 billion

$1,821,500,000.00

Assets

$2.66 billion

$2,657,500,000.00

Total Shares Outstanding

143.00 million

143,000,000

Average Daily Trading Volume

$1.46 million

$1,458,910.18

Sector

Health Care

Industry

Biotechnology

NTRA

revenue by Business Segment Natera

Revenue by Region Natera

NTRA revenue and profits

Financial Results NTRA

DRAG THE FRAME TO SEE MORE DATA

NTRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.85 29,48% (12M)

P/E

20.52

0.36%

ROE

-137.16%

P/BV

-28.15

CAH - Cardinal Health

$241.34 62,64% (12M)

P/E

37.62

0.83%

ROE

-57.93%

P/BV

-21.79

JNJ - Johnson & Johnson

$268.55 54,18% (12M)

P/E

31.48

1.90%

ROE

24.76%

P/BV

7.79

ABBV - AbbVie

$251.28 23,60% (12M)

P/E

72.11

2.66%

ROE

-106.44%

P/BV

-76.75

MRK - Merck & Co.

$148.39 83,37% (12M)

P/E

116.76

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$159.81 0,08% (12M)

P/E

19.30

1.98%

ROE

25.77%

P/BV

4.97

PFE - Pfizer

$27.90 21,65% (12M)

P/E

37.36

6.01%

ROE

5.11%

P/BV

1.91

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.85 29,48% (12 M)

P/L

20.52

0.36%

ROE

-137.16%

P/VP

-28.15

CAH - Cardinal Health

$241.34 62,64% (12 M)

P/L

37.62

0.83%

ROE

-57.93%

P/VP

-21.79

JNJ - Johnson & Johnson

$268.55 54,18% (12 M)

P/L

31.48

1.90%

ROE

24.76%

P/VP

7.79

ABBV - AbbVie

$251.28 23,60% (12 M)

P/L

72.11

2.66%

ROE

-106.44%

P/VP

-76.75

MRK - Merck & Co.

$148.39 83,37% (12 M)

P/L

116.76

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$159.81 0,08% (12 M)

P/L

19.30

1.98%

ROE

25.77%

P/VP

4.97

PFE - Pfizer

$27.90 21,65% (12 M)

P/L

37.36

6.01%

ROE

5.11%

P/VP

1.91

Frequently Asked Questions

What is the price of Natera (NTRA) today?

A cotação de Natera (NTRA) hoje está em US$ 328.18, com uma variação de 95.32% em relação ao último ano. A cotação de Natera (NTRA) iniciou o ano negociando na casa dos US$ 229.09 e hoje está em US$ 328.18. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Natera (NTRA) e dados de ações do Ibovespa e mercados internacionais.

Quando Natera (NTRA) paga dividendos?

Natera (NTRA) não distribuiu dividendos no último ano.

Is Natera (NTRA) a good investment?

Atualmente, Natera (NTRA) está cotada a US$ 328.18, com um P/L de -243.55, representando um desvio de -10,597% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 95.32 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 95.32%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Natera (NTRA) stock?

Investir em ações de Natera (NTRA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Natera (NTRA) yield today?

A rentabilidade de Natera (NTRA) foi de 2.80% no último mês, 95.32% no último ano e 175.85% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Natera (NTRA) hoje, o investimento total seria de US$ 32,818.00, com base na cotação atual de US$ 328.18.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 64,100.12
Em 5 anos: US$ 90,528.45
Em 10 anos: US$ 32,818.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NTRA

Natera Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NTRA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING NTRA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Natera

Natera Inc.

United States

19 years

2015

1.815

PROFIT X PRICE NTRA

Financial Results NTRA

NTRA cash flow

Asset, Revenue and Profit Growth - NTRA

NTRA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions